tirzepatide 10mg dosage chart Dosing for Weight Loss in Units Zepbound Dosing: Zepbound Dosage Chart,

2024;262(2):e230339

The study included 1 511 637 eligible patients with type 2 diabetes without prior diagnosis of any eye disorder who were prescribed antidiabetic medications, including 82 972 patients prescribed semaglutide or tirzepatide (63 926 patients [77.05%] prescribed semaglutide, 3815 patients [4.60%] prescribed tirzepatide, and 15 231 patients [18.36%] prescribed both medications) and 1 428 665 patients prescribed other antidiabetic medications

73 Tofogliflozin was also selected for a phase 4 trial, vs

Future studies could address these limitations by including a control group and extending the observation period